LAB
Standard Biotools Inc
0.742$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 36.8% | 40.6% | 44.1% | 49.0% | 45.4% | 45.2% | 39.7% | 40.8% | 62.2% | 52.6% | 51.7% | 50.1% | |
| 63.2% | 59.4% | 55.9% | 51.0% | 54.6% | 54.8% | 60.3% | 59.2% | 37.8% | 47.4% | 48.3% | 49.9% | |
| 37.3% | 34.2% | 36.8% | 30.2% | 26.6% | 27.0% | 26.4% | 29.1% | 38.2% | 24.4% | 35.8% | 30.5% | |
| – | – | 89.2% | 78.0% | 70.6% | 72.1% | 70.9% | 75.7% | 117.2% | 93.0% | 89.8% | 128.7% | |
| 98.5% | 106.5% | 126.0% | 108.2% | 97.2% | 99.0% | 97.3% | 110.8% | 156.5% | 119.5% | 148.8% | 159.2% | |
| -44.5% | -43.7% | -70.1% | -57.3% | -42.6% | -44.2% | -36.9% | -51.7% | -118.6% | -72.0% | -100.5% | -109.3% | |
| 4.6% | 5.1% | 5.6% | 5.7% | 12.3% | 3.6% | 2.6% | 2.9% | 4.4% | 4.3% | 1.9% | 0.0% | |
| -49.6% | -47.8% | -76.8% | -62.6% | -54.4% | -56.9% | -39.2% | -48.8% | -197.0% | -69.8% | -79.3% | -113.3% | |
| -4.2% | -1.3% | -4.0% | -3.2% | -2.1% | -1.6% | -0.8% | -3.4% | -2.9% | 0.4% | 0.3% | -44.4% | |
| -45.4% | -46.5% | -72.8% | -59.4% | -52.2% | -55.3% | -38.4% | -45.4% | -194.1% | -70.2% | -79.6% | -87.8% | |
| -33.1% | -28.7% | -54.0% | -38.9% | -27.5% | -39.8% | -25.0% | -33.9% | -177.2% | -51.2% | -67.7% | -105.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.